Navigation Links
Take Third Generation Oral Contraceptives Off the Shelves-consumer Group Insists

Public Citizen- an advocacy group for the protection of consumer health has come out strongly against the FDA//.

According to them the fact that third generation oral contraceptives have twice the risk of potentially fatal blood clots, a side effect of the synthetic hormone used in it, than second generation birth control pills, was known to the FDA, yet it has allowed the sale of these drugs for the last 12 years.

"While the use of any type of combined oral contraceptive holds an increased risk of venous thrombosis (blood clots), third-generation birth-control pills double that risk without preventing pregnancy any more effectively than older pills do” states Dr. Sidney Wolfe, director of Public Citizen's Health Research Group.

All contraceptive pills carry a very low risk of blood clots (due to venous thrombosis) that, even more rarely, can travel to the lungs and kill. It is a side effect of the pills' hormones, estrogen and progestin.

Second-generation birth-control pills contain norgestrel, levonorgestrel or norethindrone while third generation pills contain a synthetic type of progestin called desogestrel.

Third-generation birth-control pills were developed in the 1980s in an attempt to create an oral contraceptive that caused fewer side effects than earlier versions such as acne and unwanted hair.

In December 1995, three independent studies concluded that third-generation pills were about twice as likely as second-generation versions to cause blood clots. This was followed by other studies with similar results.

Accordingly users who may be subject to these potentially fatal blood clots are 30 in 100,000 as against 15 in 100,000 in those taking second-generation pills.

Yet says Vanessa Cullins, of Planned Parenthood, an organization which is opposing Public Citizens petition, ``Desogestrel pills should not be taken off the market; they are safe and very effective.

“ It is true that birth-control pills raise the incidence of blood clots over not using them, yet you have to put it into context. For women who aren't using any form of hormonal birth control and who aren't pregnant, the risk is four out of 100,000. For all birth-control pills, the risk is 10 to 30 in 100,000, while in pregnancy the risk of blood clots is 60 in 100,000.

``What we are talking about is a slight rate of increase in a very rare event. For some women desogestrel is a better choice than other drugs'', she concludes.

Yet, Public Citizen argues that since studies have shown third generation pills do not have any added advantage over second generation pills, why continue with a pill that has double the risk of blood clots?
AN
'"/>




Related medicine news :

1. Third artificial heart patient introduced
2. Third generation Small pox vaccine from Cell-culture
3. Surgery Offers Better Treatment For Third Degree Piles
4. One Third Of All Cancers Preventable!
5. Britain Announces Third Transfusion Related Mad Cow Case
6. Kleins Third Way Has Tough Opposition
7. Ignorance about AIDS rampart in Third of College Students: Chinese survey
8. Jalgaon: Third Phase Of Culling Operations Begin
9. Pramod Mahajan Undergoes Third Surgery
10. Third Arm Removed Successfully
11. Erection Drug Was Not Useful to Two-Thirds of Its Users
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:5/2/2016)... ... May 02, 2016 , ... Zitter Health ... Pharmacy Patient Satisfaction Award that will recognize specialty pharmacies for their achievements in ... Health Insights’ Specialty Pharmacy Patient Satisfaction Survey compiled throughout 2016. Results will be ...
(Date:5/2/2016)... (PRWEB) , ... May 02, ... ... researchers report that many commonly used prescription medications, including anxiolytics, painkillers, antidepressants ... mitigate these risks, Novus Medical Detox Center —a leading Florida-based drug ...
(Date:5/2/2016)... ... , ... TeleMedCo™, a new company developing real time technology ... rapid diagnosis, triage and admission of patients leveraging IBM Watson’s software and healthcare ... the first time at GENBAND’s Perspectives16 conference. , TeleMedCo selected GENBAND’s Kandy ...
(Date:5/2/2016)... ... May 02, 2016 , ... Atlantic Information Services, Inc. (AIS) is ... Payment Model Could Transform the Pharma Landscape .” CMS recently proposed a test of ... on provider-administered drugs while preserving care provided to beneficiaries. The webinar will review the ...
(Date:5/2/2016)... Beach, FL (PRWEB) , ... May 02, 2016 , ... ... to great pain and suffering. With no cure, most patients must deal with prescription ... a free coupon card, allowing up to 75% savings at the pharmacy on many ...
Breaking Medicine News(10 mins):
(Date:4/27/2016)... 27, 2016 Transparency Market Research ... Market - Global Industry Analysis, Size, Share, Growth, Trends, ... the global skincare devices market was valued at US$ ... at a CAGR of 10.1% from 2015 to 2023 ... Browse the full Skincare Devices Market (Treatment Device - LED ...
(Date:4/27/2016)... -- Tie-up with Government hospitals as part ... save newborns   Fortis La Femme, ... with Breast Milk Foundation (BMF), a non-profit organization within the ... ,Amaara, in Delhi-NCR today. This non-profit centre recognizes that breast ... should be available to babies deprived of mother,s milk.  ...
(Date:4/27/2016)... Massachusetts , April 27, 2016 ... that Jeff Poulton , Chief Financial Officer, will present ... Boston, MA on Wednesday, May 04, ... audio webcast will be available on the Presentations and Webcasts ... a replay of the webcast will be available on this ...
Breaking Medicine Technology: